EMDA-2
Pharmaceutical compound
From Wikipedia, the free encyclopedia
EMDA-2, also known as 2-ethoxy-4,5-methylenedioxyamphetamine, 6-ethoxy-MDA, or 6-ethoxy-MMDA-2, is a psychedelic drug of the phenethylamine and methylenedioxyamphetamine families.[1][2][3] It is the analogue of MMDA-2 in which the 2-methoxy group has been replaced with a 2-ethoxy group.[1][2] This has resulted in EMDA-2 being described as the "TWEETIO" analogue of MMDA-2.[1]
- None
| |
| Clinical data | |
|---|---|
| Other names | 2-Ethoxy-4,5-methylenedioxyamphetamine; 6-Ethoxy-MDA; 6-EtO-MDA; 6-Ethoxy-MMDA-2; 6-EtO-MMDA-2 |
| Routes of administration | Oral[1][2] |
| Drug class | Serotonergic psychedelic; Hallucinogen |
| ATC code |
|
| Identifiers | |
| |
| PubChem CID | |
| ChemSpider | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C12H17NO3 |
| Molar mass | 223.272 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Use and effects
EMDA-2's dose is approximately 135 to 185 mg and its duration is about 10 to 12 hours.[1][2] At 135 mg, it produced closed eye visuals, including intense colors, with sleep disturbances and a duration of some 10 hours.[1] At 185 mg, its effects were stronger, including "marvelous" closed-eye visuals with "incredible" colors, good concentration, and distinct body tingles and rushes, with insomnia and a duration of about 12 hours.[1] The potency of EMDA-2 is about one-third that of MMDA-2.[1]
Interactions
History
EMDA-2 appears to have first been described in the scientific literature by at least 1975.[3] Its effects in humans were described by Alexander Shulgin in his 1991 book PiHKAL (Phenethylamines I Have Known and Loved).[1][2]
Society and culture
Legal status
Canada
EMDA-2 may be a controlled substance in Canada under phenethylamine blanket-ban language.[4]